Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology — Stella

View on ClinicalTrials.gov

Recruiting

Back to Epilepsy trials

Trial locations(1 site)

China

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang

Key details

Sponsor

Shen Chun-Hong

Enrollment target

~300 participants

Started

August 2023

Primary completion

December 2026

Age range

14 Years – 100 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.